Fifth Third Bancorp Acquires 73,835 Shares of The Cooper Companies, Inc. $COO

Fifth Third Bancorp grew its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 1,244.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,770 shares of the medical device company’s stock after acquiring an additional 73,835 shares during the period. Fifth Third Bancorp’s holdings in Cooper Companies were worth $5,704,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the business. Root Financial Partners LLC increased its holdings in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares during the period. SJS Investment Consulting Inc. raised its holdings in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after buying an additional 187 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new stake in Cooper Companies during the 2nd quarter worth about $36,000. True Wealth Design LLC lifted its holdings in shares of Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the period. Finally, Cromwell Holdings LLC boosted its holdings in shares of Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after acquiring an additional 273 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $71.71 on Friday. The firm has a market capitalization of $13.99 billion, a PE ratio of 60.77, a price-to-earnings-growth ratio of 1.91 and a beta of 0.84. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The stock’s 50-day simple moving average is $66.24 and its 200-day simple moving average is $72.58.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same period last year, the firm posted $0.96 EPS. The company’s revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Wall Street Analyst Weigh In

COO has been the topic of several analyst reports. Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Citigroup reaffirmed a “neutral” rating and issued a $76.00 price target (up from $69.00) on shares of Cooper Companies in a research note on Wednesday, July 8th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Needham & Company LLC dropped their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. Finally, KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $81.85.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.